Tirzepatide (GLP-1/GIP) Tirzepatide is a first-in-class dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist, providing synergistic metabolic effects for diabetes and obesity research
Horibe, K., et al., Metabolic changes induced by dapagliflozin, an SGLT2 inhibitor, in Japanese patients with type 2 diabetes treated by oral anti-diabetic agents: A randomized, clinical trial
Whether youre using Sermorelin, Tesamorelin, CJC-1295, Ipamorelin, GLOW Mix, or NAD+ , this tool makes at-home peptide dosing simpler, clearer, and more accurate in seconds
For most individuals, receiving an infusion once a month is sufficient to maintain optimal glutathione levels
More visible and consistent weight loss usually occurs after several weeks to a few months of continued use